• Arnold, L.E. (2013). Commentary: Filling out the evidence base for treatment of attention-deficit hyperactivity disorder symptoms in children with intellectual and developmental disability: conclusions for clinicians – a response to Simonoff et al. (2013). Journal of Child Psychology and Psychiatry, 54, 702703.
  • Baird, G., Simonoff, E., Pickles, A., Chandler, S., Loucas, T., Meldrum, D., & Charman, T. (2006). Prevalence of disorders of the autism spectrum in a population cohort of children in South East Thames – The Special Needs and Autism Project. The Lancet, 368, 210215.
  • Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. (2005). Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Archives of General Psychiatry, 62, 12661274.
  • Rutter, M., Bailey, A., & Lord, C. (2003). The Social communication Questionnaire (1st edn). Los Angeles: Western Psychological Services.
  • Simonoff, E., Taylor, E., Baird, G., Bernard, S., Chadwick, O., Liang, H., … & Jichi, F. (2013). Randomized controlled double-blind trial of optimal dose methylphenidate in children and adolescents with severe attention deficit hyperactivity disorder and intellectual disability. Journal of Child Psychology and Psychiatry, 54, 527535.